Cargando…

A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine Effectiveness

IMPORTANCE: Little is known about COVID vaccine breakthrough infections and their risk factors. OBJECTIVE: To identify risk factors associated with COVID-19 breakthrough infections among vaccinated individuals and to reassess the effectiveness of COVID-19 vaccination against severe outcomes using re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Cong, Lee, Junghwan, Ta, Casey, Soroush, Ali, Rogers, James R., Kim, Jae Hyun, Natarajan, Karthik, Zucker, Jason, Weng, Chunhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509087/ https://www.ncbi.nlm.nih.gov/pubmed/34642696 http://dx.doi.org/10.1101/2021.10.05.21264583

Ejemplares similares

Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis
por: Liu, Cong, et al.
Publicado: (2022)

Columbia Open Health Data for COVID-19 Research: Database Analysis
por: Lee, Junghwan, et al.
Publicado: (2021)

Clinical and temporal characterization of COVID-19 subgroups using patient vector embeddings of electronic health records
por: Ta, Casey N, et al.
Publicado: (2022)

Comparative effectiveness of medical concept embedding for feature engineering in phenotyping
por: Lee, Junghwan, et al.
Publicado: (2021)

Severity Prediction for COVID-19 Patients via Recurrent Neural Networks
por: Lee, Junghwan, et al.
Publicado: (2021)

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review
por: Ledda, Caterina, et al.
Publicado: (2022)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults
por: Datwani, Sneha, et al.
Publicado: (2023)

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection
por: Evans, John P., et al.
Publicado: (2022)

Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients
por: Chumsri, Saranya, et al.
Publicado: (2021)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

The patent dispute over the breakthrough mRNA technology
por: Aquino-Jarquin, Guillermo
Publicado: (2022)

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection
por: Evans, John P., et al.
Publicado: (2021)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

POSC419 Examining the Rate of COVID-19 Breakthrough Infections in Individuals Who Received mRNA Vaccine in the United States
por: Madge, V, et al.
Publicado: (2022)

Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)
por: Schildgen, Verena, et al.
Publicado: (2022)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

mRNA-1273/ravulizumab: Breakthrough haemolysis: case report
Publicado: (2021)

Vaccines in Breast Cancer: Challenges and Breakthroughs
por: Fatima, Gul Naz, et al.
Publicado: (2023)

Breakthrough infections and waning immune responses with ChAdOx1 nCoV‐19 or mRNA vaccine in healthcare workers
por: Lim, So Yun, et al.
Publicado: (2022)

Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Chronic Inflammatory Demyelinating Polyneuropathy Post-mRNA-1273 Vaccination
por: Singh, Simranjit, et al.
Publicado: (2022)

Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination
por: Tauzin, Alexandra, et al.
Publicado: (2023)

SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
por: Santi, Theresia, et al.
Publicado: (2022)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Advances in mRNA vaccines
por: Li, Mengyun, et al.
Publicado: (2022)

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
por: Zhang, Xiaojing, et al.
Publicado: (2022)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

An Update on mRNA-Based Viral Vaccines
por: Jeeva, Subbiah, et al.
Publicado: (2021)

Breakthrough infections in MPN-COVID vaccinated patients
por: Barbui, Tiziano, et al.
Publicado: (2022)

COVID Infections Breakthrough Post-Vaccination: Systematic Review
por: Ali, Syed Amaan, et al.
Publicado: (2022)

mRNA-1273/tozinameran: Breakthrough haemolysis: 4 case reports
Publicado: (2022)

mRNA vaccines for COVID-19 and diverse diseases
por: Hussain, Abid, et al.
Publicado: (2022)

Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan
por: Naito, Toshio, et al.
Publicado: (2021)

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
por: Kustin, Talia, et al.
Publicado: (2021)

Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study
por: Ferrara, Pietro, et al.
Publicado: (2022)

Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients
por: Masetti, Marco, et al.
Publicado: (2023)

Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study
por: Schiff, Abigail E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_91co6jqm8d3htg7a7ca7pv92i9